Proposal of dual inhibitor targeting atpase domains of topoisomerase II and heat shock protein 90

Kyu Yeon Jun, Youngjoo Kwon

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

There is a conserved ATPase domain in topoisomerase II (topo II) and heat shock protein 90 (Hsp90) which belong to the GHKL (gyrase, Hsp90, histidine kinase, and MutL) family. The inhibitors that target each of topo II and Hsp90 are intensively studied as anti-cancer drugs since they play very important roles in cell proliferation and survival. Therefore the development of dual targeting anti-cancer drugs for topo II and Hsp90 is suggested to be a promising area. The topo II and Hsp90 inhibitors, known to bind to their ATP binding site, were searched. All the inhibitors investigated were docked to both topo II and Hsp90. Four candidate compounds as possible dual inhibitors were selected by analyzing the molecular docking study. The pharmacophore model of dual inhibitors for topo II and Hsp90 were generated and the design of novel dual inhibitor was proposed.

Original languageEnglish
Pages (from-to)453-468
Number of pages16
JournalBiomolecules and Therapeutics
Volume24
Issue number5
DOIs
StatePublished - Sep 2016

Keywords

  • Design of dual inhibitor
  • Heat shock protein 90
  • Molecular docking study
  • Topoisomerase II

Fingerprint

Dive into the research topics of 'Proposal of dual inhibitor targeting atpase domains of topoisomerase II and heat shock protein 90'. Together they form a unique fingerprint.

Cite this